Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04615507 · ClinicalTrials.gov registry record · NA

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
71
Enrollment target
6
Study locations

NCT04615507 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 71 participants, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04615507, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
6
Study locations

Study Summary

This is a 6-visit, subject-masked, multi-site, 2×3 crossover dispensing trial that will last approximately 2 - 4 months.

Conditions Studied

Interventions

  • DEVICE JJVC Investigational Multifocal Contact Lens
  • DEVICE Dailies Total 1® Multifocal Contact Lens

Study Locations (6)

Florida

  • Vue Optical Boutique - Jacksonville

Georgia

  • Visual Eyes, Inc. - Roswell

Missouri

  • Advanced Eye Care - Raytown

New York

  • Susquehanna Eye Care - Vestal

Ohio

  • ProCare Vision Centers - Granville

Rhode Island

  • West Bay Eye Associates - Warwick

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2020-10-09
Est. Completion 2020-12-09
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT04615507

The ClinicalTrials.gov registry entry for NCT04615507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which JJVC Investigational Multifocal Contact Lens is the first listed.

NCT04615507 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Florida, Georgia, Missouri.

Frequently Asked Questions

What is clinical trial NCT04615507 about?

NCT04615507 is a clinical study titled "Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2". This is a 6-visit, subject-masked, multi-site, 2×3 crossover dispensing trial that will last approximately 2 - 4 months.

What is the current status of trial NCT04615507?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2020-10-09. Estimated completion is 2020-12-09.

What conditions does trial NCT04615507 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT04615507?

The interventions under investigation include: JJVC Investigational Multifocal Contact Lens (DEVICE), Dailies Total 1® Multifocal Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT04615507?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04615507 being conducted?

This trial has 6 study locations across Florida, Georgia, Missouri, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.